Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 20/20 | 0.57 |
| ▸ | KLK1 | P06870 | 2/20 | 0.57 |
| ▸ | PLG | P00747 | 1/20 | 0.57 |
| ▸ | PLAT | P00750 | 1/20 | 0.57 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12133149 | 0.88 | F10 (0.62) | F10KLK1PLGPLATPRSS1 | |
| SCHEMBL12133152 | 0.88 | F10 (0.64) | F10KLK1PLGPLATPRSS1 | |
| SCHEMBL12133160 | 0.86 | F10 (0.67) | F10KLK1PLGPLATPRSS1 | |
| SCHEMBL12132434 | 0.81 | F10 (0.65) | F10KLK1PLGPLATPRSS1 | |
| SCHEMBL12133153 | 0.81 | F10 (0.57) | F10KLK1PLGPLATPRSS1 | |
| SCHEMBL18772846 | 0.79 | F10 (0.74) | F10KLK1PLGPLATPRSS1 | |
| SCHEMBL890638 | 0.78 | F10 (0.67) | F10KLK1PLGPLATPRSS1 | |
| SCHEMBL890995 | 0.78 | F10 (0.74) | F10KLK1PLGPLATPRSS1 | |
| SCHEMBL15063394 | 0.76 | F10 (0.62) | F10KLK1PLGPLATPRSS1 | |
| SCHEMBL898836 | 0.74 | F10 (0.70) | F10KLK1PLGPLATPRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10179124-B2 | Benzamides and related inhibitors of factor Xa | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2019-01-15 | — | — | US | disclosed |
| US-20180036296-A1 | BENZAMIDES AND RELATED INHIBITORS OF FACTOR XA | COR THERAPEUTICS, INC. | 2018-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180036296-A1 | BENZAMIDES AND RELATED INHIBITORS OF FACTOR XA | TFPI, F12, TFPI2 | F10 13/4885KLK1 637/4885PLG 18/4885 |
| US-10179124-B2 | Benzamides and related inhibitors of factor Xa | TFPI, F12, TFPI2 | F10 13/4885KLK1 637/4885PLG 18/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.